Pharmacogenetic analysis of high-dose methotrexate treatment in children with osteosarcoma

Inter-individual differences in toxic symptoms and pharmacokinetics of high-dose methotrexate (MTX) treatment may be caused by genetic variants in the MTX pathway. Correlations between polymorphisms and pharmacokinetic parameters and the occurrence of hepato- and myelotoxicity were studied. Single n...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Hegyi, Marta, Arany, Adam, Semsei, Agnes F., Csordas, Katalin, Eipel, Oliver, Gezsi, Andras, Kutszegi, Nora, Csoka, Monika, Muller, Judit, Erdelyi, Daniel J., Antal, Peter, Szalai, Csaba, Kovacs, Gabor T.
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2016
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5354739/
https://ncbi.nlm.nih.gov/pubmed/27566582
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.11543
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados